Suppr超能文献

用土拉弗朗西斯菌活疫苗株(LVS)接种的BALB/c和C57BL/6小鼠,经皮内注射或通过气溶胶暴露于该病原体的强毒株进行攻毒:保护效果因病原体毒力、暴露途径和宿主遗传背景而异。

Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.

作者信息

Chen Wangxue, Shen Hua, Webb Ann, KuoLee Rhonda, Conlan J Wayne

机构信息

National Research Council Canada, Institute for Biological Sciences, Ottawa, Ont., Canada K1A 0R6.

出版信息

Vaccine. 2003 Sep 8;21(25-26):3690-700. doi: 10.1016/s0264-410x(03)00386-4.

Abstract

In order to begin understanding the immunological basis for immunity to tularemia, and to establish a baseline for judging the efficacy of potential novel vaccines, the present study examined the ability of the live vaccine strain of Francisella tularensis (F. tularensis) LVS, to elicit immunity in mice against subsequent systemic and aerosol challenge with highly virulent strains of the pathogen. The results show, that infection with LVS protects BALB/c mice against systemic challenge with virulent Types A and B F. tularensis. In contrast, C57BL/6 mice vaccinated with LVS were only rendered immune to systemic challenge with Type B F. tularensis. Neither mouse strain immunized with LVS was able to resist aerosol challenge with Type A F. tularensis, and only immunized BALB/c mice withstood exposure to aerosols of Type B F. tularensis.

摘要

为了开始理解兔热病免疫的免疫学基础,并建立一个判断潜在新型疫苗效力的基线,本研究检测了土拉弗朗西斯菌(F. tularensis)LVS活疫苗株在小鼠中引发免疫以抵抗随后该病原体高毒力菌株的全身感染和气溶胶攻击的能力。结果表明,LVS感染可保护BALB/c小鼠抵抗A、B型毒力土拉弗朗西斯菌的全身感染。相比之下,接种LVS的C57BL/6小鼠仅对B型土拉弗朗西斯菌的全身感染产生免疫。两种品系的小鼠接种LVS后均无法抵抗A型土拉弗朗西斯菌的气溶胶攻击,只有接种疫苗的BALB/c小鼠能够耐受B型土拉弗朗西斯菌气溶胶的暴露。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验